NASDAQ : ZJYL
Jin Medical International Ltd. — Key statistics
Healthcare · Medical Instruments & Supplies · China
Last price 2.29 USD (Oct 30, 2026, 3:42 PM EDT) · Market cap 179.61M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 184.32M |
| Enterprise Value | 175.12M |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 73.66M |
| Shares Outstanding | 78.43M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 15.90% |
| Owned by Institutions (%) | 0.03% |
| Float | 64.84M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 15.69 |
| Forward PE | n/a |
| PS Ratio | 9.34 |
| Forward PS | n/a |
| PB Ratio | 0.61 |
| P/TBV Ratio | 6.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 149.34 |
| EV / Sales | 8.88 |
| EV / EBITDA | 266.40 |
| EV / EBIT | 419.00 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.95 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 23.88 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 4.02% |
| Return on Assets (ROA) | 0.50% |
| Return on Invested Capital (ROIC) | 1.84% |
| Return on Capital Employed (ROCE) | 1.27% |
| Weighted Average Cost of Capital (WACC) | 40.42% |
| Revenue Per Employee | $72,253 |
| Profits Per Employee | $4,295 |
| Employee Count | 273 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 2.16 |
Taxes
| Measure | Value |
|---|
| Income Tax | 98,964 |
| Effective Tax Rate | 7.84% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 7.41 |
| 52-Week Price Change | -61.03% |
| 50-Day Moving Average | 2.13 |
| 200-Day Moving Average | 2.35 |
| Relative Strength Index (RSI) | 60.86 |
| Average Volume (20 Days) | 197,499 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 49,143 |
| Short Previous Month | 70,013 |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.08% |
| Short Ratio (days to cover) | 1.75 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 19.73M |
| Gross Profit | 6.17M |
| Operating Income | 417,941 |
| Pretax Income | 1.26M |
| Net Income | 1.17M |
| EBITDA | 657,350 |
| EBIT | 417,941 |
| Earnings Per Share (EPS) | $0.15 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 30.10M |
| Total Debt | 20.90M |
| Net Cash | 9.20M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 30.15M |
| Book Value Per Share | 3.87 |
| Working Capital | 21.73M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -592,867 |
| Capital Expenditures | -6.37M |
| Depreciation & Amortization | 239,409 |
| Net Borrowing | 4.65M |
| Free Cash Flow | -6.96M |
| FCF Per Share | -$0.09 |
Margins
| Measure | Value |
|---|
| Gross Margin | 31.28% |
| Operating Margin | 2.12% |
| Pretax Margin | 6.40% |
| Profit Margin | 5.94% |
| EBITDA Margin | 3.33% |
| EBIT Margin | 2.12% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 6.37% |
| FCF Yield | -3.78% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Mar 16, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.13 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |